Salma Jabbour, MD @SalmaJabbour1 of Rutgers Cancer Institute of New Jersey @RutgersCancer discusses how patients tolerated this therapy? – Phase 2 Study of Pembro plus Platinum Doublet Chemotherapy and Radiotherapy as
First-Line Therapy for Locally Advanced NSCLC.
Salma Jabbour, MD on How Did Patients Tolerate Pembro plus Platinum Doublet Chemotherapy? @SalmaJabbour1 @RutgersCancer
By Editor